Bruno Paquin
About Bruno Paquin
Bruno Paquin CEO of AtomVie
Bruno Paquin currently holds the position of Chief Executive Officer (CEO) at AtomVie. Under his leadership, the company successfully secured at least $40 million in Series A funding. This milestone supports AtomVie's growth and development ambitions within the industry. Paquin's role involves steering the company towards sustained success.
Professional Journey at CPDC
Bruno Paquin began his tenure at CPDC in November 2018 as the Director of Business Development. His strategic vision and execution led CPDC to achieve record revenues in 2019. In November 2020, he transitioned to the role of Chief Executive Officer, continuing to drive growth and operational excellence within the company.
VP Business Development at Immuni T
Bruno Paquin served as the Vice President of Business Development at Immuni T. During his tenure, he played a pivotal role in expanding the company’s growth by 400% over a period of seven years. His contributions significantly enhanced the company’s market position and operational capacity.
Education and Academic Background of Bruno Paquin
Bruno Paquin received his PhD in Biochemistry from the Université de Montréal. His academic background has provided a solid foundation for his professional endeavors in various leadership and strategic roles within the biotech and pharmaceutical industries.
Leadership Role at Genizon Biosciences
Prior to his engagements at AtomVie and CPDC, Bruno Paquin was the Executive Director and Head of Business Development at Genizon Biosciences. His role at Genizon involved overseeing business development strategies and leading efforts to enhance the company's research and commercial activities.